Literature DB >> 24845384

Deubiquitination and stabilization of T-bet by USP10.

Lina Pan1, Zuojia Chen2, Linlin Wang1, Chen Chen2, Dan Li2, Huanying Wan1, Bin Li3, Guochao Shi4.   

Abstract

The T-box transcriptional factor T-bet is crucial in the development, differentiation and function of Th1 cells. It drives Th1 immune response primarily through promoting expression of Th1 hallmark cytokine IFN-γ. Although T-bet was found associated with many immune-mediated diseases such as asthma and systemic sclerosis, little is known about the regulation of T-bet stability and function. Here we identified USP10, a carboxyl-terminal ubiquitin-processing protease, could interact with T-bet in the nucleus. Overexpression of USP10 directly inhibited T-bet ubiquitination and increased the expression of T-bet. We further confirmed Quercetin, a reported inhibitor of T-bet, could target USP10. Quercetin treatment downregulated USP10 and promoted T-bet degradation in a proteasome dependent way. Moreover, we found USP10 expression was upregulated in asthmatic patient PBMC, suggesting USP10 may maintain high level of T-bet and IFN-γ to fight against Th2-dominated inflammation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deubiquitination; Inflammation; Quercetin; T-bet; USP10

Mesh:

Substances:

Year:  2014        PMID: 24845384     DOI: 10.1016/j.bbrc.2014.05.037

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Deubiquitylating enzymes: potential target in autoimmune diseases.

Authors:  Niraj Parihar; Lokesh Kumar Bhatt
Journal:  Inflammopharmacology       Date:  2021-11-18       Impact factor: 4.473

2.  USP10 inhibits lung cancer cell growth and invasion by upregulating PTEN.

Authors:  Jia Sun; Tianxiang Li; Yinying Zhao; Lirong Huang; Hua Sun; Hui Wu; Xiufeng Jiang
Journal:  Mol Cell Biochem       Date:  2017-08-29       Impact factor: 3.396

3.  The deubiquitylase USP10 regulates integrin β1 and β5 and fibrotic wound healing.

Authors:  Stephanie R Gillespie; Liana J Tedesco; Lingyan Wang; Audrey M Bernstein
Journal:  J Cell Sci       Date:  2017-08-29       Impact factor: 5.285

Review 4.  Ubiquitin Ligases and Deubiquitinating Enzymes in CD4+ T Cell Effector Fate Choice and Function.

Authors:  Awo A K Layman; Paula M Oliver
Journal:  J Immunol       Date:  2016-05-15       Impact factor: 5.422

5.  USP10 Expression in Normal Adrenal Gland and Various Adrenal Tumors.

Authors:  Zhi Zeng; Ziying Zhou; Na Zhan; Jingping Yuan; Baixin Ye; Lijuan Gu; Jun Wang; Zhihong Jian; Xiaoxing Xiong
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

Review 6.  Posttranscriptional regulation of T helper cell fate decisions.

Authors:  Kai P Hoefig; Vigo Heissmeyer
Journal:  J Cell Biol       Date:  2018-04-23       Impact factor: 10.539

Review 7.  Essential Kinases and Transcriptional Regulators and Their Roles in Autoimmunity.

Authors:  Ya Nan Deng; Joseph A Bellanti; Song Guo Zheng
Journal:  Biomolecules       Date:  2019-04-10

Review 8.  Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code.

Authors:  Yanfeng Wang; Feng Wang
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

9.  Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability.

Authors:  Wei Zhao; Dan Lu; Liang Liu; Juan Cai; Yu Zhou; Ying Yang; Yu Zhang; Jun Zhang
Journal:  Oncotarget       Date:  2017-09-27

10.  The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53.

Authors:  Chen Hu; Mu Zhang; Niko Moses; Cong-Li Hu; Lisa Polin; Wei Chen; Hyejeong Jang; Joshua Heyza; Agnes Malysa; Joseph A Caruso; Shengyan Xiang; Steve Patrick; Paul Stemmer; Zhenkun Lou; Wenlong Bai; Chuangui Wang; Gerold Bepler; Xiaohong Mary Zhang
Journal:  Cell Death Dis       Date:  2020-05-07       Impact factor: 9.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.